Sultosilic acid piperazine salt (Piperazine sultosylate; A-585) is a lipid-lowering agent. Sultosilic acid piperazine salt modifies the blood lipids levels, reduces platelet adhesiveness without promoting peroxisomal activity of hepatocytes or producing other adverse side-effects.
References:
[1]. Vinazzer H, et al., Double-blind cross-over study of the effect of sultosilic acid piperazine salt (A-585) and bezafibrate in primary perlipoproteinemia. Atherosclerosis. 1983 Nov;49(2):109-18.